Hemodialysis-associated cardiomyopathy: a newly defined disease entity

C W McIntyre, A Odudu

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Cardiovascular disease is the most common cause of the greatly elevated rates of mortality characteristic of patients undergoing maintenance hemodialysis. This article is an attempt to describe the complex and evolving features of cardiac disease routinely encountered in HD patients. Furthermore, by trying to appreciate the pathophysiological drivers, and the crucial interaction with the HD treatment itself, this article seeks to define cardiac disease in this setting (HD-associated cardiomyopathy) as a unique and complex entity. By understanding the phenotype and basis of HD-associated cardiomyopathy, we can develop an evolved understanding of the dominant processes involved in its development and offer up dialysis-based interventions specifically designed to mitigate the cumulative ischemic insults consequent to conventional HD treatment. This article explores the justification of this approach and recent evidence of its efficacy.
    Original languageEnglish
    Pages (from-to)87-97
    Number of pages11
    JournalSemin Dial
    Volume27
    Issue number2
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'Hemodialysis-associated cardiomyopathy: a newly defined disease entity'. Together they form a unique fingerprint.

    Cite this